Numinus CEO Payton Nyquvest Answers Investor Questions And Gives Look-Ahead Outlook For 2023 Dec 30, 2022
Lobe Sciences Hopes To Move Novel Psilocin Drug Compounds Quickly Through The FDA Funnel Nov 22, 2022
atai Life Sciences Investor Christian Angermayer On The Company’s Low Valuation And Late-Stage Pipeline Nov 16, 2022
